Clover Health Investments, Corp
CLOV
Positions held
Your positionsCLOV isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Clover Health is positioned in a growing healthcare industry, focusing on innovative health plans that cater to underserved populations.
- Clover Health's revenue showed a slight decrease of 1% in the latest quarter, totaling $743 million, but it reflects a strong growth trajectory with a 55.6% revenue growth year-over-year.
- The company has a current ratio of 1.501, indicating a solid liquidity position to cover short-term liabilities.
- The healthcare plans industry is highly competitive, and Clover Health faces challenges in maintaining profitability.
- Clover Health reported a net income loss of $213.361 million in 2023, with an operating margin of -14.24%, highlighting ongoing financial struggles.
- The company's profit margin stands at -0.74%, indicating that it is currently not generating profit from its revenues.
Fundamentals
| Market cap | $2.43B | Enterprise value | $2.19B | Trailing P/E | — | Forward P/E | 30.53 |
| PEG | — | Price / book | 6.44 | Beta | 2.46 | Dividend yield | 0.00% |
| Revenue growth | 55.6% | Earnings growth | — | Gross margin | 18.5% | Operating margin | 3.8% |
| Profit margin | -0.7% | ROE | -5.1% | ROA | -1.8% | Debt / equity | — |
| Current ratio | 1.50 | Free cash flow | $69.05M | Analyst recommendation | none | Mean target | $5.38 |
| 52w high | $5.59 | 52w low | $1.58 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $743M | $749M | $488M | $497M | $478M | — |
| Op margin | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | — |
| Net income | $28.0M | $27.3M | -$49.3M | -$24.4M | -$10.6M | — |
| Gross margin | 20.6% | 21.3% | 15.2% | 14.7% | 20.9% | — |
| Gross profit | $153M | $160M | $74.2M | $73.2M | $99.6M | — |
| Operating income | $28.0M | $27.3M | -$49.3M | -$24.4M | -$10.6M | — |
- Revenue -1% vs prior quarter ($743M vs $749M).
- Gross margin 20.6% (was 21.3% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $1.3B | $1.1B | — |
| Op margin | -4.4% | -3.3% | -14.2% | -26.1% | — |
| Net income | -$85.5M | -$43.0M | -$213M | -$340M | — |
| Gross margin | 18.5% | 26.6% | 20.3% | 9.4% | — |
| Gross profit | $356M | $365M | $256M | $103M | — |
| Operating income | -$85.5M | -$45.5M | -$180M | -$287M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
2026-10-08 · Humana Soars On Medicare Advantage Star Rating
2026-10-07 · Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
2026-10-04 · Clover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap?
2026-10-02 · 3 Great Healthcare Stocks To Own In October 2026
2026-10-01 · 1 Small-Cap Stock to Own for Decades and 2 Facing Headwinds
2026-10-01 · Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
2026-09-25 · 1 Cash-Producing Stock on Our Buy List and 2 We Ignore
2026-09-23 · NIO Stock And 2 Penny Stocks To Watch
Price (daily)
Full chart · RSI · MACD · patterns